Economic implications of current age-related macular degeneration treatments.

Abstract

PURPOSE To measure the cost versus benefit of age-related macular degeneration (AMD) treatment strategies, existing and proposed, in the postranibizumab era. DESIGN Cost-effectiveness model. PARTICIPANTS None. METHODS University with hospital-based practice modeling of clinical examination, imaging, and treatment schedules were constructed considering… (More)
DOI: 10.1016/j.ophtha.2008.10.029

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics